Skip to main content

CAR-T cell therapy: MS Clinical Trials

4 active trials · 4 recruiting

4 active multiple sclerosis clinical trials involve CAR-T cell therapy, 4 currently recruiting. The list is matched on the interventions registered at ClinicalTrials.gov, so it includes head-to-head comparisons and studies where this therapy is the comparator as well as the treatment under test.

Trial results are not treatment advice: whether a therapy is right for you depends on your type of MS, disease activity and history, which is a conversation for your neurologist.

Active CAR-T cell therapy MS trials

RecruitingPhase 1

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

Sponsor: Stanford University
KYV-101 anti-CD19 CAR-T cell therapy · Standard lymphodepletion regimen
1 state12 participantsDetails ›
RecruitingPhase 1

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Sponsor: Daishi Tian
CD19/BCMA-targeted CAR-T cells · Lymphodepleting Conditioning
36 participantsDetails ›
RecruitingPhase 1

A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Sponsor: RenJi Hospital
CD20/BCMA-directed CAR-T cells
30 participantsDetails ›

MS trials by therapy

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play